PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination.

PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. J Clin Invest. 2023 02 01; 133(3).

View in: PubMed